Form 4: Neurocrine Biosciences Director Rastetter Contributes Shares to Exchange Fund
SEC Form 4
Director William H Rastetter contributed 14,250 shares of Neurocrine Biosciences (NBIX) common stock to an exchange fund on August 15, 2024.
Summary
- On August 15, 2024, William H Rastetter, a director of Neurocrine Biosciences Inc. (NBIX), contributed 14,250 shares of common stock to an exchange fund.
- The shares were valued at $146.69 each for the purpose of determining the number of shares of the exchange fund issuable to Rastetter.
- Following the transaction, Rastetter beneficially owns 37,491 shares of Neurocrine Biosciences common stock, held by the Rastetter Family Trust established September 2, 2010.
- Rastetter has voting and investment power over these shares.
Sentiment
Score: 5
Explanation: The document is a standard Form 4 filing, indicating a transaction by a company insider. It doesn't inherently convey positive or negative sentiment about the company's performance or future prospects.
Industry Context
This transaction reflects a director's portfolio management activity and may not necessarily indicate a change in sentiment towards the company's prospects. Contributions to exchange funds are often part of diversification strategies.
Key Dates
| Date | Description |
|---|---|
| 2010-09-02 | Date the Rastetter Family Trust was established. |
| 2024-08-15 | Date of the transaction where shares were contributed to an exchange fund. |
| 2024-08-16 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.